Bone marrow cell therapy ameliorates and reverses chagasic cardiomyopathy in a mouse model

Regina C.S. Goldenberg, Linda A. Jelicks, Fabio S.A. Fortes, Louis M. Weiss, Leonardo L. Rocha, Dazhi Zhao, Antonio Campos De Carvalho, David C. Spray, Herbert B. Tanowitz

Research output: Contribution to journalArticle

33 Scopus citations

Abstract

Chronic chagasic cardiomyopathy, which is caused by the protozoan Trypanosoma cruzi, is a major cause of heart failure in Latin America. It is a disease for which effective treatment in its advanced clinical forms is lacking. We have previously shown that bone marrow mononuclear cell (BMC) transplantation is effective in reducing inflammation and fibrosis in the mouse model of Chagas disease. The present study used magnetic resonance imaging to assess changes in the cardiac morphology of infected mice after therapy with BMCs. Serial imaging of the BMC-treated mice revealed regression of the right ventricular dilatation typically observed in the chagasic mouse model.

Original languageEnglish (US)
Pages (from-to)544-547
Number of pages4
JournalJournal of Infectious Diseases
Volume197
Issue number4
DOIs
StatePublished - Feb 15 2008

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Bone marrow cell therapy ameliorates and reverses chagasic cardiomyopathy in a mouse model'. Together they form a unique fingerprint.

  • Cite this

    Goldenberg, R. C. S., Jelicks, L. A., Fortes, F. S. A., Weiss, L. M., Rocha, L. L., Zhao, D., De Carvalho, A. C., Spray, D. C., & Tanowitz, H. B. (2008). Bone marrow cell therapy ameliorates and reverses chagasic cardiomyopathy in a mouse model. Journal of Infectious Diseases, 197(4), 544-547. https://doi.org/10.1086/526793